Gaziano, J M <br/><br/>
Aspirin in the treatment and prevention of cardiovascular disease.  [electronic resource] 

 -  Haemostasis  2000 
 - 1-13 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Review 
<br/><br/><label>ISSN: </label>0301-0147 
<br/><br/><label>Standard No.: </label>10.1159/000054193  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Acute Disease<br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Aspirin--adverse effects<br/>Cardiovascular Diseases--drug therapy<br/>Case-Control Studies<br/>Cohort Studies<br/>Coronary Disease--drug therapy<br/>Cost-Benefit Analysis<br/>Cyclooxygenase Inhibitors--pharmacology<br/>Drug Costs<br/>Drug Labeling<br/>Drug Utilization<br/>Female<br/>Fibrinolytic Agents--therapeutic use<br/>Hemorrhage--chemically induced<br/>Humans<br/>Male<br/>Meta-Analysis as Topic<br/>Middle Aged<br/>Myocardial Infarction--drug therapy<br/>Myocardial Revascularization<br/>Platelet Aggregation Inhibitors--adverse effects<br/>Postoperative Complications--prevention & control<br/>Practice Guidelines as Topic<br/>Randomized Controlled Trials as Topic<br/>Recurrence<br/>Streptokinase--therapeutic use<br/>Stroke--prevention & control<br/>Thrombolytic Therapy<br/>Thrombosis--prevention & control<br/>Treatment Outcome